Voloridge Investment Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-340,953
| Closed | -$4.51M | – | 1364 |
|
|
2024
Q4 | $4.51M | Buy |
340,953
+204,911
| +151% | +$2.71M | 0.02% | 804 |
|
|
2024
Q3 | $1.93M | Buy |
+136,042
| New | +$1.93M | 0.01% | 938 |
|
|
2024
Q1 | – | Sell |
-502,492
| Closed | -$7.17M | – | 1351 |
|
|
2023
Q4 | $7.17M | Sell |
502,492
-70,025
| -12% | -$999K | 0.03% | 543 |
|
|
2023
Q3 | $8.86M | Sell |
572,517
-9,149
| -2% | -$142K | 0.04% | 487 |
|
|
2023
Q2 | $9.14M | Sell |
581,666
-435,102
| -43% | -$6.84M | 0.04% | 484 |
|
|
2023
Q1 | $16.8M | Sell |
1,016,768
-111,604
| -10% | -$1.84M | 0.08% | 328 |
|
|
2022
Q4 | $17.6M | Buy |
1,128,372
+173,345
| +18% | +$2.7M | 0.1% | 291 |
|
|
2022
Q3 | $12.4M | Sell |
955,027
-69,226
| -7% | -$898K | 0.07% | 383 |
|
|
2022
Q2 | $14.4M | Buy |
1,024,253
+706,697
| +223% | +$9.92M | 0.07% | 344 |
|
|
2022
Q1 | $4.55M | Buy |
317,556
+160,304
| +102% | +$2.3M | 0.03% | 669 |
|
|
2021
Q4 | $2.14M | Buy |
+157,252
| New | +$2.14M | 0.01% | 1047 |
|
|
2021
Q2 | – | Sell |
-73,452
| Closed | -$1.34M | – | 1782 |
|
|
2021
Q1 | $1.34M | Buy |
73,452
+20,591
| +39% | +$376K | 0.01% | 941 |
|
|
2020
Q4 | $962K | Sell |
52,861
-73,695
| -58% | -$1.34M | 0.01% | 978 |
|
|
2020
Q3 | $2.26M | Buy |
126,556
+50,838
| +67% | +$907K | 0.02% | 678 |
|
|
2020
Q2 | $1.36M | Sell |
75,718
-1,854
| -2% | -$33.3K | 0.02% | 746 |
|
|
2020
Q1 | $1.18M | Sell |
77,572
-290,044
| -79% | -$4.4M | 0.03% | 470 |
|
|
2019
Q4 | $7.25M | Buy |
367,616
+183,443
| +100% | +$3.62M | 0.14% | 184 |
|
|
2019
Q3 | $3.17M | Buy |
184,173
+162,428
| +747% | +$2.79M | 0.06% | 344 |
|
|
2019
Q2 | $385K | Buy |
+21,745
| New | +$385K | 0.01% | 610 |
|